Comparison of cytology, HPV DNA testing and HPV 16/18 genotyping alone or combined targeting to the more balanced methodology for cervical cancer screening

Gynecologic Oncology

Volumn 142, Issue 1, 2016, Pages 120-127

  Chatzistamatiou, Kimon ^a   Moysiadis, Theodoros ^b   Moschaki, Viktoria ^a   Panteleris, Nikolaos ^a   Agorastos, Theodoros ^a  

^a Aristotle University and Hippokration General Hospital   (Greece)

^b INFORMATION TECHNOLOGIES INSTITUTE   (Greece)

Author keywords

Cervical cancer screening; Cervical Intraepithelial Neoplasia; HPV genotyping; HPV testing; Human papillomavirus; Triage to colposcopy

Indexed keywords

ADULT; ARTICLE; CANCER DIAGNOSIS; CANCER SCREENING; COLPOSCOPY; DIAGNOSTIC ACCURACY; FEMALE; GENOTYPE; HUMAN; HUMAN PAPILLOMAVIRUS DNA TESTING; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN PAPILLOMAVIRUS TYPE 18; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MIDDLE AGED; MOLECULAR DIAGNOSIS; PRIORITY JOURNAL; UTERINE CERVIX BIOPSY; UTERINE CERVIX CANCER; UTERINE CERVIX CARCINOMA IN SITU; UTERINE CERVIX CYTOLOGY; ALGORITHM; CERVICAL INTRAEPITHELIAL NEOPLASIA; GENETICS; INFORMATION PROCESSING; ISOLATION AND PURIFICATION; PAPILLOMAVIRUS INFECTIONS; PATHOLOGY; UTERINE CERVICAL NEOPLASMS; VIROLOGY;

VIRUS DNA;

ALGORITHMS; CERVICAL INTRAEPITHELIAL NEOPLASIA; DATASETS AS TOPIC; DNA, VIRAL; FEMALE; GENOTYPE; HUMAN PAPILLOMAVIRUS 16; HUMAN PAPILLOMAVIRUS 18; HUMANS; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; UTERINE CERVICAL NEOPLASMS;

EID: 84975167068     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2016.04.027     Document Type: Article

References (34)

1. V. Bouvard, R. Baan, K. Straif, Y. Grosse, B. Secretan, F. El Ghissassi, L. Benbrahim-Tallaa, N. Guha, C. Freeman, L. Galichet, V. Cogliano, and Group WHOIAfRoCMW A review of human carcinogens-part B: biological agents Lancet Oncol. 10 2009 321 322
2. M. Schiffman, P.E. Castle, J. Jeronimo, A.C. Rodriguez, and S. Wacholder Human papillomavirus and cervical cancer Lancet 370 2007 890 907
3. N.G. Campos, E.A. Burger, S. Sy, M. Sharma, M. Schiffman, A.C. Rodriguez, A. Hildesheim, R. Herrero, and J.J. Kim An updated natural history model of cervical cancer: derivation of model parameters Am. J. Epidemiol. 180 2014 545 555
4. J.T. Schiller, X. Castellsagué, and S.M. Garland A review of clinical trials of human papillomavirus prophylactic vaccines Vaccine 30 Suppl. 5 2012 F123 F138
5. E.A. Joura, A.R. Giuliano, O.E. Iversen, C. Bouchard, C. Mao, J. Mehlsen, E.D. Moreira Jr., Y. Ngan, L.K. Petersen, E. Lazcano-Ponce, P. Pitisuttithum, J.A. Restrepo, G. Stuart, L. Woelber, Y.C. Yang, J. Cuzick, S.M. Garland, W. Huh, S.K. Kjaer, O.M. Bautista, I.S. Chan, J. Chen, R. Gesser, E. Moeller, M. Ritter, S. Vuocolo, A. Luxembourg, and Broad Spectrum HPV vaccine study A 9-valent HPV vaccine against infection and intraepithelial neoplasia in women N. Engl. J. Med. 372 2015 711 723
6. T. Agorastos, K. Chatzistamatiou, T. Katsamagkas, G. Koliopoulos, A. Daponte, T. Constantinidis, T.C. Constantinidis, and the Hsg Primary screening for cervical cancer based on high-risk human papillomavirus (HPV) detection and HPV 16 and HPV 18 genotyping, in comparison to cytology PLoS One 10 2015 e0119755
7. D. Solomon, D. Davey, R. Kurman, A. Moriarty, D. O'Connor, M. Prey, S. Raab, M. Sherman, D. Wilbur, T. Wright Jr., N. Young, M. Forum Group, and W. Bethesda The 2001 Bethesda system: terminology for reporting results of cervical cytology JAMA 287 2002 2114 2119
8. J. Bornstein, J. Bentley, P. Bosze, F. Girardi, H. Haefner, M. Menton, M. Perrotta, W. Prendiville, P. Russell, M. Sideri, B. Strander, S. Tatti, A. Torne, and P. Walker 2011 colposcopic terminology of the International Federation for Cervical Pathology and Colposcopy Obstet. Gynecol. 120 2012 166 172
9. R.M. Richart A modified terminology for cervical intraepithelial neoplasia Obstet. Gynecol. 75 1990 131 133
10. L. Sharp, S. Cotton, A.E. Carsin, N. Gray, A. Thornton, M. Cruickshank, J. Little, and T. Group Factors associated with psychological distress following colposcopy among women with low-grade abnormal cervical cytology: a prospective study within the trial of management of borderline and other low-grade abnormal smears (TOMBOLA) Psychooncology 22 2013 368 380
11. M. O'Connor, P. Gallagher, J. Waller, C.M. Martin, J.J. O'Leary, L. Sharp, and C. Irish Cervical Screening Research Adverse psychological outcomes following colposcopy and related procedures: a systematic review BJOG 123 2016 24 38
12. J.T. Cox, P.E. Castle, C.M. Behrens, A. Sharma, T.C. Wright Jr., J. Cuzick, and Athena HPV study group Comparison of cervical cancer screening strategies incorporating different combinations of cytology, HPV testing, and genotyping for HPV 16/18: results from the ATHENA HPV study Am. J. Obstet. Gynecol. 208 184 2013 (e1-184 e11)
13. G. Ronco, P. Giorgi-Rossi, F. Carozzi, M. Confortini, P. Dalla Palma, A. Del Mistro, A. Gillio-Tos, D. Minucci, C. Naldoni, R. Rizzolo, P. Schincaglia, R. Volante, M. Zappa, M. Zorzi, J. Cuzick, N. Segnan, and New Technologies for Cervical Cancer Screening Working G Results at recruitment from a randomized controlled trial comparing human papillomavirus testing alone with conventional cytology as the primary cervical cancer screening test J. Natl. Cancer Inst. 100 2008 492 501
14. D.C. Rijkaart, J. Berkhof, F.J. van Kemenade, V.M. Coupe, A.T. Hesselink, L. Rozendaal, D.A. Heideman, R.H. Verheijen, S. Bulk, W.M. Verweij, P.J. Snijders, and C.J. Meijer Evaluation of 14 triage strategies for HPV DNA-positive women in population-based cervical screening Int. J. Cancer 130 2012 602 610
15. C.E. Depuydt, A.P. Makar, M.J. Ruymbeke, I.H. Benoy, A.J. Vereecken, and J.J. Bogers BD-ProExC as adjunct molecular marker for improved detection of CIN2 + after HPV primary screening Cancer Epidemiol. Biomark. Prev. 20 2011 628 637
16. J. Cuzick, C. Clavel, K.U. Petry, C.J. Meijer, H. Hoyer, S. Ratnam, A. Szarewski, P. Birembaut, S. Kulasingam, P. Sasieni, and T. Iftner Overview of the European and North American studies on HPV testing in primary cervical cancer screening Int. J. Cancer 119 2006 1095 1101
17. T. Agorastos, K. Chatzistamatiou, M. Zafrakas, V. Siamanta, T. Katsamagkas, T.C. Constantinidis, A.F. Lampropoulos, and group Ls Epidemiology of HPV infection and current status of cervical cancer prevention in Greece: final results of the LYSISTRATA cross-sectional study Eur. J. Cancer Prev. 23 2014 425 431
18. P.E. Castle, M.H. Stoler, T.C. Wright Jr., A. Sharma, T.L. Wright, and C.M. Behrens Performance of carcinogenic human papillomavirus (HPV) testing and HPV16 or HPV18 genotyping for cervical cancer screening of women aged 25 years and older: a subanalysis of the ATHENA study Lancet Oncol. 12 2011 880 890
19. G. Ronco, J. Dillner, K.M. Elfstrom, S. Tunesi, P.J. Snijders, M. Arbyn, H. Kitchener, N. Segnan, C. Gilham, P. Giorgi-Rossi, J. Berkhof, J. Peto, C.J. Meijer, and International HPVswg Efficacy of HPV-based screening for prevention of invasive cervical cancer: follow-up of four European randomised controlled trials Lancet 383 2014 524 532
20. D.C. Rijkaart, J. Berkhof, L. Rozendaal, F.J. van Kemenade, N.W. Bulkmans, D.A. Heideman, G.G. Kenter, J. Cuzick, P.J. Snijders, and C.J. Meijer Human papillomavirus testing for the detection of high-grade cervical intraepithelial neoplasia and cancer: final results of the POBASCAM randomised controlled trial Lancet Oncol. 13 2012 78 88
21. G. Ronco, P. Giorgi-Rossi, F. Carozzi, M. Confortini, P. Dalla Palma, A. Del Mistro, B. Ghiringhello, S. Girlando, A. Gillio-Tos, L. De Marco, C. Naldoni, P. Pierotti, R. Rizzolo, P. Schincaglia, M. Zorzi, M. Zappa, N. Segnan, J. Cuzick, and New Technologies for Cervical Cancer screening Working G Efficacy of human papillomavirus testing for the detection of invasive cervical cancers and cervical intraepithelial neoplasia: a randomised controlled trial Lancet Oncol. 11 2010 249 257
22. H.C. Kitchener, M. Almonte, C. Thomson, P. Wheeler, A. Sargent, B. Stoykova, C. Gilham, H. Baysson, C. Roberts, R. Dowie, M. Desai, J. Mather, A. Bailey, A. Turner, S. Moss, and J. Peto HPV testing in combination with liquid-based cytology in primary cervical screening (ARTISTIC): a randomised controlled trial Lancet Oncol. 10 2009 672 682
23. P. Naucler, W. Ryd, S. Tornberg, A. Strand, G. Wadell, K. Elfgren, T. Radberg, B. Strander, B. Johansson, O. Forslund, B.G. Hansson, E. Rylander, and J. Dillner Human papillomavirus and Papanicolaou tests to screen for cervical cancer N. Engl. J. Med. 357 2007 1589 1597
24. I.J. Korfage, M.L. Essink-Bot, S.M. Westenberg, T. Helmerhorst, J.D. Habbema, and M. van Ballegooijen How distressing is referral to colposcopy in cervical cancer screening?: a prospective quality of life study Gynecol. Oncol. 132 2014 142 148
25. T.T. Kwan, A.N. Cheung, S.S. Lo, P.W. Lee, K.F. Tam, K.K. Chan, and H.Y. Ngan Psychological burden of testing positive for high-risk human papillomavirus on women with atypical cervical cytology: a prospective study Acta Obstet. Gynecol. Scand. 90 2011 445 451
26. D. Solomon Chapter 14: role of triage testing in cervical cancer screening J. Natl. Cancer Inst. Monogr. 2003 97 101
27. S. de Sanjose, W.G. Quint, L. Alemany, D.T. Geraets, J.E. Klaustermeier, B. Lloveras, S. Tous, A. Felix, L.E. Bravo, H.-R. Shin, C.S. Vallejos, P.A. de Ruiz, M.A. Lima, N. Guimera, O. Clavero, M. Alejo, A. Llombart-Bosch, C. Cheng-Yang, S.A. Tatti, E. Kasamatsu, E. Iljazovic, M. Odida, R. Prado, M. Seoud, M. Grce, A. Usubutun, A. Jain, G.A.H. Suarez, L.E. Lombardi, A. Banjo, C. Menéndez, E.J. Domingo, J. Velasco, A. Nessa, S.C.B. Chichareon, Y.L. Qiao, E. Lerma, S.M. Garland, T. Sasagawa, A. Ferrera, D. Hammouda, L. Mariani, A. Pelayo, I. Steiner, E. Oliva, C.J. Meijer, W.F. Al-Jassar, E. Cruz, T.C. Wright, A. Puras, C.L. Llave, M. Tzardi, T. Agorastos, V. Garcia-Barriola, C. Clavel, J. Ordi, M. Andújar, X. Castellsagué, G.I. Sánchez, A.M. Nowakowski, J. Bornstein, N. Muñoz, F.X. Bosch, and Retrospective International S, Group HPVTTS Human papillomavirus genotype attribution in invasive cervical cancer: a retrospective cross-sectional worldwide study Lancet Oncol. 11 2010 1048 1056
28. N. Munoz, F.X. Bosch, S. de Sanjose, R. Herrero, X. Castellsague, K.V. Shah, P.J. Snijders, C.J. Meijer, and International Agency for Research on Cancer Multicenter Cervical Cancer Study G Epidemiologic classification of human papillomavirus types associated with cervical cancer N. Engl. J. Med. 348 2003 518 527
29. T.C. Wright, M.H. Stoler, C.M. Behrens, A. Sharma, G. Zhang, and T.L. Wright Primary cervical cancer screening with human papillomavirus: End of study results from the ATHENA study using HPV as the first-line screening test Gynecol. Oncol. 136 2015 189 197
30. A. Skroumpelos, T. Agorastos, K. Chatzistamatiou, T. Akalestos, N. Poulios, and J. Kyriopoulos Budget impact analysis of high-risk Hpv Dna (Hrhpv) test with 16/18 genotyping as a primary screening method for cervical cancer in Greece Value Health 18 2015 A349
31. D. Saslow, D. Solomon, H.W. Lawson, M. Killackey, S.L. Kulasingam, J. Cain, F.A. Garcia, A.T. Moriarty, A.G. Waxman, D.C. Wilbur, N. Wentzensen, L.S. Downs Jr., M. Spitzer, A.B. Moscicki, E.L. Franco, M.H. Stoler, M. Schiffman, P.E. Castle, E.R. Myers, American Cancer S, American Society for C, Cervical P, and American Society for Clinical P. American Cancer Society American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer Am. J. Clin. Pathol. 137 2012 516 542
32. A.J. Blatt, R. Kennedy, R.D. Luff, R.M. Austin, and D.S. Rabin Comparison of cervical cancer screening results among 256,648 women in multiple clinical practices Cancer Cytopathol. 123 2015 282 288
33. J.C. Gage, M. Schiffman, H.A. Katki, P.E. Castle, B. Fetterman, N. Wentzensen, N.E. Poitras, T. Lorey, L.C. Cheung, and W.K. Kinney Reassurance against future risk of precancer and cancer conferred by a negative human papillomavirus test J. Natl. Cancer Inst. 106 2014
34. W.K. Huh, K.A. Ault, D. Chelmow, D.D. Davey, R.A. Goulart, F.A. Garcia, W.K. Kinney, L.S. Massad, E.J. Mayeaux, D. Saslow, M. Schiffman, N. Wentzensen, H.W. Lawson, and M.H. Einstein Use of primary high-risk human papillomavirus testing for cervical cancer screening: Interim clinical guidance Obstet. Gynecol. 125 2015 330 337